OrfoNeuro ApS: Financial statements 2023
CVR: 37768901
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
OrfoNeuro ApS (CVR 37768901) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -147,740 and a net result of DKK -208,111 compared with DKK -95,046 the year before. Equity in the 2023 report amounted to DKK -807,523.
- Gross Profit
- DKK -147,740
- Profit/Loss
- DKK -208,111
- Equity
- DKK -807,523
- Total Assets
- DKK 47,136
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -148K | -208K | -808K | 0 |
| 2022 | - | -90K | -95K | -599K | 0 |
| 2021 | - | -79K | -88K | -504K | 0 |
| 2020 | - | -155K | -153K | -416K | 0 |
| 2019 | - | -146K | -140K | -263K | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
OrfoNeuro ApS has published its annual report for 2022. Gross profit came to DKK -90,228, and the net result was DKK -95,046.
About OrfoNeuro ApS
OrfoNeuro ApS is a Danish company of the type Anpartsselskab based in Lynge, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Morten Fogh. The board consists of Ulrik Spork (chair), Jens Morten Fogh and Per Toft Valstorp. The company is owned by VALSTORP & COMPANY ApS, JIMKKS Holding ApS and Claes Magnus Andersson. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -267,558 and a net result of DKK -289,729 compared with DKK -242,569 the year before. Equity in the 2025 report amounted to DKK 9,545.